| 1 |
Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 [J]. Lancet, 2015, 386(10010): 2287-2323.
|
| 2 |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
|
| 3 |
Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation-have anti-inflammatory therapies come of age? [J]. Nat Rev Clin Oncol, 2021, 18(5): 261-279.
|
| 4 |
宁波. 肿瘤免疫与肿瘤免疫逃逸机制 [J]. 中国实用妇科与产科杂志, 2000, 16(6): 339-340.
|
| 5 |
Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance [J]. Annu Rev Pathol, 2021,16: 223-249.
|
| 6 |
Galon J, Bruni D. Bruni, tumor immunology and tumor evolution: intertwined histories [J]. Immunity, 2020, 52(1): 55-81.
|
| 7 |
Dolladille C, Ederhy S, Sassier M, et al., Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer [J]. JAMA Oncol, 2020, 6(6): 865-871.
|
| 8 |
Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells [J]. Nat Cell Biol, 2007, 9(6): 654-659.
|
| 9 |
Becker A, Thakur BK, Weiss JM, et al., Extracellular vesicles in cancer: cell-to-cell mediators of metastasis [J]. Cancer Cell, 2016, 30(6): 836-848.
|
| 10 |
Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance [J]. Mol Cancer, 2019, 18(1): 75.
|
| 11 |
Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer [J]. Mol Cancer, 2017, 16(1): 94.
|
| 12 |
Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer [J]. Mol Cancer, 2017, 16(1): 25.
|
| 13 |
Jeck WR, Sharpless NE. Sharpless, detecting and characterizing circular RNAs [J]. Nat Biotechnol, 2014, 32(5): 453-461.
|
| 14 |
Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis [J]. Cell Res, 2015, 25(8): 981-984.
|
| 15 |
Shi X, Wang B, Feng X, et al. circRNAs and exosomes: A mysterious frontier for human cancer [J]. Mol Ther Nucleic Acids, 2020, 19: 384-392.
|
| 16 |
Chen T, Liu Y, Li C, et al. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis [J]. Cancer Treat Res Commun, 2021, 28: 100412.
|
| 17 |
Yi Y, Wu M, Zeng H, et al. Tumor-derived exosomal non-coding RNAs: The emerging mechanisms and potential clinical applications in breast cancer [J]. Front Oncol, 2021, 11: 738945.
|
| 18 |
Gao J, Ao YQ, Zhang LX, et al. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1 [J]. J Exp Clin Cancer Res, 2022, 41(1): 295.
|
| 19 |
Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma [J]. Cell Death Dis, 2020, 11(1): 32.
|
| 20 |
Katopodi T, Petanidis S, Domvri K, et al. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit [J]. Sci Rep, 2021, 11(1): 15455.
|
| 21 |
Luo YH, Yang YP, Chien CS, et al. Circular RNA hsa_circ_0000190 facilitates the tumorigenesis and immune evasion by upregulating the expression of soluble PD-L1 in non-small-cell lung cancer [J]. Int J Mol Sci, 2021, 23(1): 64.
|
| 22 |
Chen SW, Zhu SQ, Pei X, et al. Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC [J]. Mol Cancer, 2021, 20(1): 144.
|
| 23 |
Chen W, Tang D, Lin J, et al., Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis [J]. Mol Ther Oncolytics, 2022, 24: 470-485.
|
| 24 |
Wang D, Cabalag CS, Clemons NJ, et al., Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer [J]. Gastroenterology, 2021, 161(6): 1813-1829.
|
| 25 |
Song J, Xu X, He S, et al. Exosomal hsa_circ_0017252 attenuates the development of gastric cancer via inhibiting macrophage M2 polarization [J]. Hum Cell, 2022, 35(5): 1499-1511.
|
| 26 |
Lu Q, Wang X, Zhu J, et al. Hypoxic tumor-derived exosomal circ0048117 facilitates M2 macrophage polarization acting as miR-140 sponge in esophageal squamous cell carcinoma [J]. Onco Targets Ther, 2020, 13: 11883-11897.
|
| 27 |
Wang X, Wang G, Wu Z, et al. Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma [J]. Mol Ther Nucleic Acids, 2023, 31: 151-163.
|
| 28 |
Huang M, Huang X, Huang N. Huang, exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells [J]. Cancer Sci, 2022, 113(6): 1968-1983.
|
| 29 |
Lu JC, Zhang PF, Huang XY, et al. Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma [J]. J Hematol Oncol, 2021, 14(1): 200.
|
| 30 |
Wang Y, Gao R, Li J, et al. Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via Interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization [J]. Int J Nanomedicine, 2021, 16: 2803-2818.
|
| 31 |
Zhang PF, Gao C, Huang XY, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma [J]. Mol Cancer, 2020, 19(1): 110.
|
| 32 |
Lei T, Zhang Y, Wang X, et al. Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer [J]. Front Immunol, 2022, 13: 919014.
|
| 33 |
Pan Z, Zhao R, Li B, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3 [J]. Mol Cancer, 2022, 21(1): 16.
|
| 34 |
Huang X, Wang J, Guan J, et al. Exosomal circsafb2 reshaping tumor environment to promote renal cell carcinoma progression by mediating M2 macrophage polarization [J]. Front Oncol, 2022, 12: 808888.
|
| 35 |
Chen Y, Li Z, Liang J, et al., CircRNA has_circ_0069313 induced OSCC immunity escape by miR-325-3p-Foxp3 axes in both OSCC cells and Treg cells [J]. Aging (Albany NY), 2022, 14(10): 4376-4389.
|
| 36 |
Yang SJ, Wang DD, Zhong SL, et al. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis [J]. Cell Death Dis, 2021, 12(5): 420.
|
| 37 |
Lu C, Shi W, Hu W, et al. Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression [J]. Pharmacol Res, 2022, 177: 106098.
|
| 38 |
Wang X, Yao Y, Jin M. Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells [J]. Aging (Albany NY), 2020, 12(19): 19095-19106.
|
| 39 |
Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics [J]. Adv Drug Deliv Rev, 2017, 114: 206-221.
|
| 40 |
Chen S, Chen Z, Li Z, et al. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256 [J]. Cell Death Dis, 2022, 13(1): 94.
|
| 41 |
Gu X, Shi Y, Dong M, et al. Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer [J]. Cell Death Dis, 2021, 12(9): 818.
|
| 42 |
Xu H, Zhu J, Smith S, et al., Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization [J]. Nat Immunol, 2012, 13(7): 642-650.
|
| 43 |
Zhang L, Zhang J, Li P, et al., Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3 [J]. Cell Death Dis, 2022, 13(1): 32.
|
| 44 |
Shi L, Cao Y, Yuan W, et al. Exosomal circRNA BTG2 derived from RBP-J overexpressed-macrophages inhibits glioma progression via miR-25-3p/PTEN [J]. Cell Death Dis, 2022, 13(5): 506.
|
| 45 |
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis [J]. Nat Med, 2013, 19(11): 1423-1437.
|
| 46 |
Yang K, Zhang J, Bao C. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis [J]. BMC Cancer, 2021, 21(1): 933.
|
| 47 |
Gao F, Chiu SM, Motan DA, et al., Mesenchymal stem cells and immunomodulation: current status and future prospects [J]. Cell Death Dis, 2016, 7(1): e2062.
|
| 48 |
Gao G, Wang L, Li C. Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma [J]. Am J Cancer Res, 2022, 12(5): 1934-1959.
|
| 49 |
赵静静,张康. 髓源性抑制细胞在肿瘤免疫治疗中的研究近况 [J]. 右江医学, 2020, 48(4): 300-303.
|
| 50 |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023 [J]. CA Cancer J Clin, 2023, 73(1): 17-48.
|
| 51 |
Gao F, Xu Q, Tang Z, et al. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1 [J]. J Transl Med, 2022, 20(1): 346.
|
| 52 |
胡冬至, 孔大陆. 结直肠癌免疫检查点抑制剂研究进展 [J/OL]. 中华临床医师杂志(电子版), 2021, 15(9): 712-715.
|